by Wei Liu, Ph.D. | Aug 22, 2018 | Blog
Month: August 2018 FollowFollowFollow Colorectal cancer (CRC), including colon and rectum cancer, is the third most common cancer in the world and the third in the US as well. American Cancer Society (ACS) estimates that there are 97,220 and 43,030 new cases in 2018...
by Wei Liu, Ph.D. | Aug 7, 2018 | Blog
Month: August 2018 FollowFollowFollow When mutated, oncogenes can convert normal cells to cancer cells. BRAF is one of the oncogenes that controls transduction of chemical signal from outside the cells to nucleus. As a member of the RAS/MAPK pathway, the BRAF gene...
by Media Coverage | Aug 1, 2018 | Blog
Media Coverage FollowFollowFollow Molecular Diagnostics has evolved over the years and the numerous benefits it has to offer has earned people’s attention irrespective of the expensive procedures it included. Quicker turnaround times, improved sensitivities, increased...
by Media Coverage | Jul 2, 2018 | Blog
Month: July 2018 FollowFollowFollow At a pathology lab, a researcher is working on a patient’s blood sample to extract cell-free DNA to find the potential diagnostic biomarker for cancers. Using the current DNA sequencing techniques such as next-generation sequencing...
by DiaCarta Inc. | Jul 2, 2018 | Blog
Month: July 2018 FollowFollowFollow 1. The challenges that our clients faced Acute myeloid leukemia (AML) is an aggressive hematopoietic neoplasm characterized by an accumulation of myeloid cells in the bone marrow because of impaired differentiation and...
by Media Coverage | Jul 1, 2018 | Blog
Month: July 2018 FollowFollowFollow Headquartered in Richmond, California with an ISO 13485 and CLIA certified facility, DiaCarta develops, manufactures, and markets cancer research and IVD products and performs molecular testing ‘liquid biopsy’ services for precision...
Recent Comments